Your browser doesn't support javascript.
loading
Residual Learning Diagnosis Detection: An Advanced Residual Learning Diagnosis Detection System for COVID-19 in Industrial Internet of Things.
Zhang, Mingdong; Chu, Ronghe; Dong, Chaoyu; Wei, Jianguo; Lu, Wenhuan; Xiong, Naixue.
Affiliation
  • Zhang M; College of Intelligence and ComputingTianjin University Tianjin 300072 China.
  • Chu R; College of Intelligence and ComputingTianjin University Tianjin 300072 China.
  • Dong C; Nanyang Technological University Singapore 639798 Singapore.
  • Wei J; College of Intelligence and ComputingTianjin University Tianjin 300072 China.
  • Lu W; College of Intelligence and ComputingTianjin University Tianjin 300072 China.
  • Xiong N; Department of Mathematics and Computer Science, Northeastern State University Tahlequah OK 74464 USA.
IEEE Trans Industr Inform ; 17(9): 6510-6518, 2021 Sep.
Article in En | MEDLINE | ID: mdl-37981910
ABSTRACT
Due to the fast transmission speed and severe health damage, COVID-19 has attracted global attention. Early diagnosis and isolation are effective and imperative strategies for epidemic prevention and control. Most diagnostic methods for the COVID-19 is based on nucleic acid testing (NAT), which is expensive and time-consuming. To build an efficient and valid alternative of NAT, this article investigates the feasibility of employing computed tomography images of lungs as the diagnostic signals. Unlike normal lungs, parts of the lungs infected with the COVID-19 developed lesions, ground-glass opacity, and bronchiectasis became apparent. Through a public dataset, in this article, we propose an advanced residual learning diagnosis detection (RLDD) scheme for the COVID-19 technique, which is designed to distinguish positive COVID-19 cases from heterogeneous lung images. Besides the advantage of high diagnosis effectiveness, the designed residual-based COVID-19 detection network can efficiently extract the lung features through small COVID-19 samples, which removes the pretraining requirement on other medical datasets. In the test set, we achieve an accuracy of 91.33%, a precision of 91.30%, and a recall of 90%. For the batch of 150 samples, the assessment time is only 4.7 s. Therefore, RLDD can be integrated into the application programming interface and embedded into the medical instrument to improve the detection efficiency of COVID-19.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IEEE Trans Industr Inform Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IEEE Trans Industr Inform Year: 2021 Type: Article